A citation-based method for searching scientific literature

Nadja Niclauss, Ines Gütgemann, Jonas Dohmen, Jörg C Kalff, Philipp Lingohr. Cancers (Basel) 2021
Times Cited: 4







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
75

Current treatment and recent progress in gastric cancer.
Smita S Joshi, Brian D Badgwell. CA Cancer J Clin 2021
177
50

Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis.
Du-Min Go, Seung Hyun Lee, Su-Hyung Lee, Sang-Ho Woo, Kibyeong Kim, Kyeongdae Kim, Kyu Seong Park, Jong-Hwan Park, Sang-Jun Ha, Woo Ho Kim,[...]. Cell Mol Gastroenterol Hepatol 2021
7
25

PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.
Lihu Gu, Manman Chen, Dongyu Guo, Hepan Zhu, Wenchao Zhang, Junhai Pan, Xin Zhong, Xinlong Li, Haoran Qian, Xianfa Wang. PLoS One 2017
127
25

Research Progress and Challenges in the Treatment of Central Nervous System Metastasis of Non-Small Cell Lung Cancer.
Bin Wang, Hanfei Guo, Haiyang Xu, Hongquan Yu, Yong Chen, Gang Zhao. Cells 2021
3
33

Pathogenesis of Helicobacter pylori infection.
Vania Camilo, Toshiro Sugiyama, Eliette Touati. Helicobacter 2017
67
25

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.
Sylvie Lantuejoul, Ming Sound-Tsao, Wendy A Cooper, Nicolas Girard, Fred R Hirsch, Anja C Roden, Fernando Lopez-Rios, Deepali Jain, Teh-Ying Chou, Noriko Motoi,[...]. J Thorac Oncol 2020
133
25


Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials.
Joseph Chao, Charles S Fuchs, Kohei Shitara, Josep Tabernero, Kei Muro, Eric Van Cutsem, Yung-Jue Bang, Ferdinando De Vita, Gregory Landers, Chia-Jui Yen,[...]. JAMA Oncol 2021
59
25

The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.
Minghui Zhang, Yuandi Dong, Haitao Liu, Yan Wang, Shu Zhao, Qijia Xuan, Yan Wang, Qingyuan Zhang. Sci Rep 2016
88
25

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Vyara Matson, Jessica Fessler, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria-Luisa Alegre, Jason J Luke, Thomas F Gajewski. Science 2018
25

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
Zachary R Chalmers, Caitlin F Connelly, David Fabrizio, Laurie Gay, Siraj M Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki,[...]. Genome Med 2017
25

Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy.
Anastasia Constantinidou, Constantinos Alifieris, Dimitrios T Trafalis. Pharmacol Ther 2019
164
25

The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Vancheswaran Gopalakrishnan, Beth A Helmink, Christine N Spencer, Alexandre Reuben, Jennifer A Wargo. Cancer Cell 2018
503
25

Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
Elizabeth C Paver, Wendy A Cooper, Andrew J Colebatch, Peter M Ferguson, Sean K Hill, Trina Lum, Joo-Shik Shin, Sandra O'Toole, Lyndal Anderson, Richard A Scolyer,[...]. Pathology 2021
35
25

Gastric cancer.
Elizabeth C Smyth, Magnus Nilsson, Heike I Grabsch, Nicole Ct van Grieken, Florian Lordick. Lancet 2020
762
25

Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection.
Loryn Holokai, Jayati Chakrabarti, Taylor Broda, Julie Chang, Jennifer A Hawkins, Nambirajan Sundaram, Lydia E Wroblewski, Richard M Peek, Jiang Wang, Michael Helmrath,[...]. PLoS Pathog 2019
75
25

Melanoma.
Dirk Schadendorf, David E Fisher, Claus Garbe, Jeffrey E Gershenwald, Jean-Jacques Grob, Allan Halpern, Meenhard Herlyn, Michael A Marchetti, Grant McArthur, Antoni Ribas,[...]. Nat Rev Dis Primers 2015
275
25

Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection.
Soumita Das, Giovanni Suarez, Ellen J Beswick, Johanna C Sierra, David Y Graham, Victor E Reyes. J Immunol 2006
126
25

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
25

Helicobacter urease suppresses cytotoxic CD8+ T-cell responses through activating Myh9-dependent induction of PD-L1.
Jian Wu, Xiaowen Zhu, Xia Guo, Ze Yang, Qinzhen Cai, Dongmei Gu, Wei Luo, Chunhui Yuan, Yun Xiang. Int Immunol 2021
4
25

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.
Caroline Robert, Antoni Ribas, Jacob Schachter, Ana Arance, Jean-Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona M McNeil, Michal Lotem,[...]. Lancet Oncol 2019
470
25


Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Jonathan E Rosenberg, Jean Hoffman-Censits, Tom Powles, Michiel S van der Heijden, Arjun V Balar, Andrea Necchi, Nancy Dawson, Peter H O'Donnell, Ani Balmanoukian, Yohann Loriot,[...]. Lancet 2016
25

Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.
James K Y Hooi, Wan Ying Lai, Wee Khoon Ng, Michael M Y Suen, Fox E Underwood, Divine Tanyingoh, Peter Malfertheiner, David Y Graham, Vincent W S Wong, Justin C Y Wu,[...]. Gastroenterology 2017
25



Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Kohei Shitara, Eric Van Cutsem, Yung-Jue Bang, Charles Fuchs, Lucjan Wyrwicz, Keun-Wook Lee, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee,[...]. JAMA Oncol 2020
256
25

Relationship between Helicobacter pylori and expression of programmed death-1 and its ligand in gastric intraepithelial neoplasia and early-stage gastric cancer.
Bo Shen, Aihua Qian, Wenji Lao, Weiguang Li, Xi Chen, Benyan Zhang, Huafeng Wang, Fei Yuan, Yunwei Sun. Cancer Manag Res 2019
11
25

Helicobacter pylori cag pathogenicity island's role in B7-H1 induction and immune evasion.
Taslima T Lina, Shatha Alzahrani, Jennifer House, Yoshio Yamaoka, Arlene H Sharpe, Bill A Rampy, Irina V Pinchuk, Victor E Reyes. PLoS One 2015
25
25

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.
Arlene H Sharpe, E John Wherry, Rafi Ahmed, Gordon J Freeman. Nat Immunol 2007
25


Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Euno Choi, Mee Soo Chang, Sun-Ju Byeon, Heejin Jin, Kyeong Cheon Jung, Haeryoung Kim, Kook Lae Lee, Won Kim, Jin Hyun Park, Ki Hwan Kim,[...]. Diagn Pathol 2020
16
25

Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer.
Jacek Baj, Izabela Korona-Głowniak, Alicja Forma, Amr Maani, Elżbieta Sitarz, Mansur Rahnama-Hezavah, Elżbieta Radzikowska, Piero Portincasa. Cells 2020
49
25

Lipopolysaccharide Structure and Biosynthesis in Helicobacter pylori.
Hong Li, Tingting Liao, Aleksandra W Debowski, Hong Tang, Hans-Olof Nilsson, Keith A Stubbs, Barry J Marshall, Mohammed Benghezal. Helicobacter 2016
39
25

Current status of immune checkpoint inhibitors for gastric cancer.
Koji Kono, Shotaro Nakajima, Kosaku Mimura. Gastric Cancer 2020
62
25

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Hossein Borghaei, Scott Gettinger, Everett E Vokes, Laura Q M Chow, Marco Angelo Burgio, Javier de Castro Carpeno, Adam Pluzanski, Oscar Arrieta, Osvaldo Arén Frontera, Rita Chiari,[...]. J Clin Oncol 2021
121
25

Gastric Microenvironment-A Partnership between Innate Immunity and Gastric Microbiota Tricks Helicobacter pylori.
Cristina Oana Mărginean, Lorena Elena Meliț, Maria Oana Săsăran. J Clin Med 2021
6
25

Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha,[...]. N Engl J Med 2015
25

Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study.
David F McDermott, Jeffrey A Sosman, Mario Sznol, Christophe Massard, Michael S Gordon, Omid Hamid, John D Powderly, Jeffrey R Infante, Marcella Fassò, Yan V Wang,[...]. J Clin Oncol 2016
382
25


Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment.
Jacek Baj, Alicja Forma, Monika Sitarz, Piero Portincasa, Gabriella Garruti, Danuta Krasowska, Ryszard Maciejewski. Cells 2020
44
25

Immunotherapy in upper GI malignancies.
Adrian Murphy, Ronan J Kelly. Curr Treat Options Oncol 2015
7
25


Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).
Shota Fukuoka, Hiroki Hara, Naoki Takahashi, Takashi Kojima, Akihito Kawazoe, Masako Asayama, Takako Yoshii, Daisuke Kotani, Hitomi Tamura, Yuichi Mikamoto,[...]. J Clin Oncol 2020
229
25

Helicobacter pylori infection associates with fecal microbiota composition and diversity.
Fabian Frost, Tim Kacprowski, Malte Rühlemann, Corinna Bang, Andre Franke, Kathrin Zimmermann, Matthias Nauck, Uwe Völker, Henry Völzke, Reiner Biffar,[...]. Sci Rep 2019
27
25

Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy.
Eleni Panagioti, Cheyne Kurokawa, Kimberly Viker, Arun Ammayappan, S Keith Anderson, Sotiris Sotiriou, Kyriakos Chatzopoulos, Katayoun Ayasoufi, Aaron J Johnson, Ianko D Iankov,[...]. J Clin Invest 2021
14
25

Advances in clinical immunotherapy for gastric cancer.
Kexin Li, Ashley Zhang, Xiaoya Li, Hongtao Zhang, Lianmei Zhao. Biochim Biophys Acta Rev Cancer 2021
14
25

Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation.
Isabelle C Arnold, Mariela Artola-Borán, Paulino Tallón de Lara, Andreas Kyburz, Christian Taube, Karen Ottemann, Maries van den Broek, Shida Yousefi, Hans-Uwe Simon, Anne Müller. J Exp Med 2018
61
25

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.
Marie Vétizou, Jonathan M Pitt, Romain Daillère, Patricia Lepage, Nadine Waldschmitt, Caroline Flament, Sylvie Rusakiewicz, Bertrand Routy, Maria P Roberti, Connie P M Duong,[...]. Science 2015
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.